Literature DB >> 35526442

A novel liquid crystal resonance Rayleigh scattering spectral probe for determination of trace Cr6.

Shengfu Zhi1, Chongning Li2, Zhiliang Jiang3.   

Abstract

Hexavalent chromium (Cr6+) has strong oxidizing property and toxicity. It has been identified as a carcinogen with obvious carcinogenic effect by the International Anti-cancer Research Center. Therefore, it has a great significance to establish a simple and sensitive method for Cr6+. In the solution, liquid crystal (LC) trans, trans-4-(3,4-difluorophenyl)-4'-n-pentylbicyclohexyl (DP) exhibits strong resonance Rayleigh scattering (RRS) effect due to formation DP nanoparticles. It was used firstly as nanoprobe, to establish a simple and sensitive RRS energy transfer (RRS-ET) method for the determination of trace Cr6+ in water samples. The Cr6+ reacts with diphenylcarbazide (DCB) to produce purple complex. It is adsorbed on the nanoprobe surface, the purple complex as energy receptor and DP as energy donor to produce RRS-ET phenomenon, to make the RRS signal of 370 nm decreasing. In the range of 3-30 nmol/L Cr6+, with the increase of concentration, the RRS signal decreased linearly at 370 nm, with a detection limit of 0.49 nmol/L. This new RRS-ET method was applied to the determination of Cr6+ in water samples, with recovery of 96.0-104.7% and the relative standard deviation (RSD) of 4.44-9.98%.
Copyright © 2022 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cr(6+); Diphenylcarbazide; Liquid crystal nanoprobe; RRS-energy transfer

Mesh:

Substances:

Year:  2022        PMID: 35526442     DOI: 10.1016/j.saa.2022.121306

Source DB:  PubMed          Journal:  Spectrochim Acta A Mol Biomol Spectrosc        ISSN: 1386-1425            Impact factor:   4.098


  1 in total

1.  Construction of Effective Nanosensor by Combining Semiconducting Polymer Dots with Diphenylcarbazide for Specific Recognition of Trace Cr (VI) Ion in Water and Vitro.

Authors:  Xilin Dou; Quan Wang; Tao Zhu; Zhaoyang Ding; Jing Xie
Journal:  Nanomaterials (Basel)       Date:  2022-08-03       Impact factor: 5.719

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.